Is D2 lymphadenectomy for gastric cancer a staging tool or a therapeutic intervention? Review uri icon

Overview

abstract

  • The extent of lymphadenectomy for gastric cancer is a controversial topic widely debated by those treating the disease. Regional differences in outcome have been noted between patients treated in Japan centers and those treated in Western centers. Technical differences have been investigated within the context of two large, prospective randomized trials, which found no benefit to more extensive lymphadenectomy procedures with increased morbidity. Subsets of patients being treated for cure may benefit from extended resections. The impact of tumor features, such as depth of invasion and number of metastatic lymph nodes, has been described and incorporated into current staging systems. The role of enhanced pathologic evaluation of surgical specimens and impact on staging and treatment strategies is evolving.

publication date

  • April 1, 2002

Research

keywords

  • Lymph Node Excision
  • Stomach Neoplasms

Identity

Scopus Document Identifier

  • 0036544965

Digital Object Identifier (DOI)

  • 10.1016/s1055-3207(02)00008-x

PubMed ID

  • 12424860

Additional Document Info

volume

  • 11

issue

  • 2